Biliary tract cancer (BTC), a rare malignancy that grows within the bile ducts and gallbladder, grows very aggressively.  The ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology showed that chemotherapy combining three different ...

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...

SGPGI Lucknow developed a new treatment regimen combining chemotherapy and radiotherapy for gallbladder cancer. Led by Professor Sushma Agrawal, the five-year study revealed improved life expectancy ...

The SGPGI Lucknow has developed a new treatment regimen for gallbladder cancer patients, which could nearly double their life expectancy while costing a fraction of the expensive immunotherapy, ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...